14-3-3σ and Its Modulators in Cancer

14-3-3σ is an acidic homodimer protein with more than one hundred different protein partners associated with oncogenic signaling and cell cycle regulation. This review aims to highlight the crucial role of 14-3-3σ in controlling tumor growth and apoptosis and provide a detailed discussion on the str...

Full description

Bibliographic Details
Main Authors: Ghazi Aljabal, Beow Keat Yap
Format: Article
Language:English
Published: MDPI AG 2020-12-01
Series:Pharmaceuticals
Subjects:
Online Access:https://www.mdpi.com/1424-8247/13/12/441
id doaj-e95310b31dc648118435c7006dfe02ea
record_format Article
spelling doaj-e95310b31dc648118435c7006dfe02ea2020-12-04T00:02:36ZengMDPI AGPharmaceuticals1424-82472020-12-011344144110.3390/ph1312044114-3-3σ and Its Modulators in CancerGhazi Aljabal0Beow Keat Yap1School of Pharmaceutical Sciences, Universiti Sains Malaysia, Gelugor 11800, Penang, MalaysiaSchool of Pharmaceutical Sciences, Universiti Sains Malaysia, Gelugor 11800, Penang, Malaysia14-3-3σ is an acidic homodimer protein with more than one hundred different protein partners associated with oncogenic signaling and cell cycle regulation. This review aims to highlight the crucial role of 14-3-3σ in controlling tumor growth and apoptosis and provide a detailed discussion on the structure–activity relationship and binding interactions of the most recent 14-3-3σ protein-protein interaction (PPI) modulators reported to date, which has not been reviewed previously. This includes the new fusicoccanes stabilizers (FC-NAc, DP-005), fragment stabilizers (TCF521-123, TCF521-129, AZ-003, AZ-008), phosphate-based inhibitors (IMP, PLP), peptide inhibitors (2a–d), as well as inhibitors from natural sources (85531185, 95911592). Additionally, this review will also include the discussions of the recent efforts by a different group of researchers for understanding the binding mechanisms of existing 14-3-3σ PPI modulators. The strategies and state-of-the-art techniques applied by various group of researchers in the discovery of a different chemical class of 14-3-3σ modulators for cancer are also briefly discussed in this review, which can be used as a guide in the development of new 14-3-3σ modulators in the near future.https://www.mdpi.com/1424-8247/13/12/441protein-protein interaction (PPI)14-3-3σdimerstabilizerinhibitorcancer
collection DOAJ
language English
format Article
sources DOAJ
author Ghazi Aljabal
Beow Keat Yap
spellingShingle Ghazi Aljabal
Beow Keat Yap
14-3-3σ and Its Modulators in Cancer
Pharmaceuticals
protein-protein interaction (PPI)
14-3-3σ
dimer
stabilizer
inhibitor
cancer
author_facet Ghazi Aljabal
Beow Keat Yap
author_sort Ghazi Aljabal
title 14-3-3σ and Its Modulators in Cancer
title_short 14-3-3σ and Its Modulators in Cancer
title_full 14-3-3σ and Its Modulators in Cancer
title_fullStr 14-3-3σ and Its Modulators in Cancer
title_full_unstemmed 14-3-3σ and Its Modulators in Cancer
title_sort 14-3-3σ and its modulators in cancer
publisher MDPI AG
series Pharmaceuticals
issn 1424-8247
publishDate 2020-12-01
description 14-3-3σ is an acidic homodimer protein with more than one hundred different protein partners associated with oncogenic signaling and cell cycle regulation. This review aims to highlight the crucial role of 14-3-3σ in controlling tumor growth and apoptosis and provide a detailed discussion on the structure–activity relationship and binding interactions of the most recent 14-3-3σ protein-protein interaction (PPI) modulators reported to date, which has not been reviewed previously. This includes the new fusicoccanes stabilizers (FC-NAc, DP-005), fragment stabilizers (TCF521-123, TCF521-129, AZ-003, AZ-008), phosphate-based inhibitors (IMP, PLP), peptide inhibitors (2a–d), as well as inhibitors from natural sources (85531185, 95911592). Additionally, this review will also include the discussions of the recent efforts by a different group of researchers for understanding the binding mechanisms of existing 14-3-3σ PPI modulators. The strategies and state-of-the-art techniques applied by various group of researchers in the discovery of a different chemical class of 14-3-3σ modulators for cancer are also briefly discussed in this review, which can be used as a guide in the development of new 14-3-3σ modulators in the near future.
topic protein-protein interaction (PPI)
14-3-3σ
dimer
stabilizer
inhibitor
cancer
url https://www.mdpi.com/1424-8247/13/12/441
work_keys_str_mv AT ghazialjabal 1433sanditsmodulatorsincancer
AT beowkeatyap 1433sanditsmodulatorsincancer
_version_ 1724401055558533120